Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.

Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM.

Gynecol Oncol. 2000 Aug;78(2):123-9.

PMID:
10926790
2.

Chapter 17: Genital human papillomavirus infections--current and prospective therapies.

Stanley M.

J Natl Cancer Inst Monogr. 2003;(31):117-24. Review.

PMID:
12807955
3.

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.

Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF.

Gynecol Oncol. 2004 Mar;92(3):873-80.

PMID:
14984955
4.

[Preliminary study on the relationship between loads of human papillomavirus in cervical carcinoma and cervical intraepithelial neoplasia].

Li SM, Zhang WH, Wu LY, Zhao FH, Huang MN, Li N, Chen F.

Zhonghua Fu Chan Ke Za Zhi. 2004 Jun;39(6):400-2. Chinese.

PMID:
15312325
5.

Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.

Del Priore G, Gudipudi DK, Montemarano N, Restivo AM, Malanowska-Stega J, Arslan AA.

Gynecol Oncol. 2010 Mar;116(3):464-7. doi: 10.1016/j.ygyno.2009.10.060.

PMID:
19939441
6.

High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.

Fontaine J, Hankins C, Mayrand MH, Lefevre J, Money D, Gagnon S, Rachlis A, Pourreaux K, Ferenczy A, Coutlée F; Canadian Women's HIV Study Group..

AIDS. 2005 May 20;19(8):785-94.

PMID:
15867492
7.
8.

Evaluation of adenoassociated virus 2 and human papilloma virus 16 and 18 infection in cervical cancer biopsies.

Ahn WS, Bae SM, Chung JE, Lee HK, Kim BK, Lee JM, Namkoong SE, Kim CK, Sin J.

Gynecol Oncol. 2003 Apr;89(1):105-11.

PMID:
12694662
9.
10.

Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol.

Crum CP, Beach KJ, Hedley ML, Yuan L, Lee KR, Wright TC, Urban RG.

J Infect Dis. 2004 Apr 15;189(8):1348-54.

PMID:
15073670
11.

The role treatment for cervical intraepithelial neoplasia plays in the disappearance of human papilloma virus.

Aschkenazi-Steinberg SO, Spitzer BJ, Spitzer M.

J Low Genit Tract Dis. 2005 Jan;9(1):19-22.

PMID:
15870517
12.

Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women.

Hernández-Hernández DM, Ornelas-Bernal L, Guido-Jiménez M, Apresa-Garcia T, Alvarado-Cabrero I, Salcedo-Vargas M, Mohar-Betancourt A, Garcia-Carranca A.

Gynecol Oncol. 2003 Aug;90(2):310-7.

PMID:
12893192
13.
14.
15.

Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections.

Bekkers RL, Bulten J, Wiersma-van Tilburg A, Mravunac M, Schijf CP, Massuger LF, Quint WG, Melchers WJ.

Br J Cancer. 2003 Sep 1;89(5):886-90.

16.

Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis?

Agorastos T, Chrisafi S, Lambropoulos AF, Mikos T, Constandinides TC, Schlehofer JR, Schlehofer B, Kotsis A, Bontis JN.

Eur J Cancer Prev. 2008 Aug;17(4):364-8. doi: 10.1097/CEJ.0b013e3282b6fd2e.

PMID:
18562963
17.

HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.

Zielinski GD, Rozendaal L, Voorhorst FJ, Berkhof J, Snijders PJ, Risse EJ, Runsink AP, de Schipper FA, Meijer CJ.

Gynecol Oncol. 2003 Oct;91(1):67-73.

PMID:
14529664
18.
20.

Natural history and clearance of HPV after treatment of precancerous cervical lesions.

Aerssens A, Claeys P, Garcia A, Sturtewagen Y, Velasquez R, Vanden Broeck D, Vansteelandt S, Temmerman M, Cuvelier CA.

Histopathology. 2008 Feb;52(3):381-6. doi: 10.1111/j.1365-2559.2007.02956.x.

PMID:
18269589

Supplemental Content

Support Center